On April 21, 2023, FCM MM Holdings, LLC announces that it has filed a preliminary proxy statement in connection with its nomination of 4 director candidates, Scott Freeman, Farzin Farzaneh, Vivek Jain, and Alexander Wodka, for election to the board of directors of Mind Medicine (MindMed) Inc. at its 2023 annual general meeting. FCM MM Holdings stated that it is committed to addressing the Company's significant challenges and unlocking shareholder value.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.125 USD | -1.16% | -3.85% | +121.99% |
May. 13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
May. 08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+121.99% | 591M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- FCM MM Holdings Nominates Director Candidates to Restore MindMed’s Value